Function, therapeutic potential and cell biology of BACE proteases: Current status and future prospects

Journal of Neurochemistry

Volumn 130, Issue 1, 2014, Pages 4-28

  Vassar, Robert ^a   Kuhn, Peer Hendrik ^b,c,d   Haass, Christian ^b,e,f   Kennedy, Matthew E ^g,h   Rajendran, Lawrence ^h   Wong, Philip C ⁱ   Lichtenthaler, Stefan F ^b,c,d,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e Technische Universität München Munich Cluster for Systems Neurology   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g MERCK RESEARCH LABORATORIES   (United States)

^h UNIVERSITY OF ZURICH   (Switzerland)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; BACE1; BACE2; protease; regulated intramembrane proteolysis; secretase

Indexed keywords

5,6 DIHYDRO 2 IMINO 3 METHYL 6 [4 [5 (1 PROPYNYL) 3 PYRIDINYL] 2 THIENYL] 4 PYRIMIDINONE; AMYLOID BETA PROTEIN; AVAGACESTAT; BETA SECRETASE; BETA SECRETASE 1; BETA SECRETASE 2; BETA SECRETASE INHIBITOR; LY 2811376; LY 2886721; MYELIN; NEU DIFFERENTIATION FACTOR; SEMAGACESTAT; UNCLASSIFIED DRUG; AMYLOID PRECURSOR PROTEIN; APP PROTEIN, HUMAN; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; SECRETASE;

ALZHEIMER DISEASE; BINDING AFFINITY; BINDING SITE; CELL MIGRATION; CELLULAR DISTRIBUTION; CLINICAL EFFECTIVENESS; DISEASE ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME SUBSTRATE; HUMAN; IC 50; IN VIVO STUDY; LIVER TOXICITY; MOLECULAR PATHOLOGY; MUSCLE SPINDLE; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENZYMOLOGY; FORECASTING; INTRACELLULAR FLUID; PHYSIOLOGY; PROTEIN TRANSPORT;

MUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; FORECASTING; HUMANS; INTRACELLULAR FLUID; PROTEIN TRANSPORT;

EID: 84903190262     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12715     Document Type: Review

References (213)

1. Akpinar P., Kuwajima S., Krutzfeldt J., and, Stoffel M., (2005) Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation. Cell Metab. 2, 385-397.
2. Albert J. S., (2009) Progress in the development of beta-secretase inhibitors for Alzheimer's disease. Prog. Med. Chem. 48, 133-161.
3. Andersen O. M., Reiche J., Schmidt V., et al,. (2005) Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc. Natl Acad. Sci. USA 102, 13461-13466. (Pubitemid 41420870)
4. Andrechek E. R., Hardy W. R., Girgis-Gabardo A. A., Perry R. L., Butler R., Graham F. L., Kahn R. C., Rudnicki M. A., and, Muller W. J., (2002) ErbB2 is required for muscle spindle and myoblast cell survival. Mol. Cell. Biol. 22, 4714-4722. (Pubitemid 34620407)
5. von Arnim C. A., Spoelgen R., Peltan I. D., et al,. (2006) GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing. J. Neurosci. 26, 9913-9922. (Pubitemid 44477153)
6. Atwal J. K., Chen Y., Chiu C., et al,. (2011) A therapeutic antibody targeting BACE1 inhibits amyloid-beta production in vivo. Sci. Transl. Med., 3, 84ra43.
7. Bang M. L., and, Owczarek S., (2013) A matter of balance: role of neurexin and neuroligin at the synapse. Neurochem. Res. 38, 1174-1189.
8. Bao J., Wolpowitz D., Role L. W., and, Talmage D. A., (2003) Back signaling by the Nrg-1 intracellular domain. J. Cell Biol. 161, 1133-1141. (Pubitemid 36870174)
9. Bao J., Lin H., Ouyang Y., et al,. (2004) Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. Nat. Neurosci. 7, 1250-1258. (Pubitemid 39426245)
10. Basi G., Frigon N., Barbour R., Doan T., Gordon G., McConlogue L., Sinha S., and, Zeller M., (2003) Antagonistic effects of beta-site amyloid precursor protein-cleaving enzymes 1 and 2 on beta-amyloid peptide production in cells. J. Biol. Chem. 278, 31512-31520. (Pubitemid 37048328)
11. Bateman R. J., Siemers E. R., Mawuenyega K. G., et al,. (2009) A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system. Ann. Neurol. 66, 48-54.
12. Bateman R. J., Xiong C., Benzinger T. L., et al,. (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367, 795-804.
13. van Bebber F., Hruscha A., Willem M., Schmid B., and, Haass C., (2013) Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes. J. Neurochem. 127, 471-481.
14. Benjannet S., Elagoz A., Wickham L., et al,. (2001) Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J. Biol. Chem. 276, 10879-10887. (Pubitemid 38089265)
15. Bennett B. D., Babu-Khan S., Loeloff R., Louis J. C., Curran E., Citron M., and, Vassar R., (2000a) Expression analysis of BACE2 in brain and peripheral tissues. J. Biol. Chem. 275, 20647-20651. (Pubitemid 30457651)
16. Bennett B. D., Denis P., Haniu M., Teplow D. B., Kahn S., Louis J. C., Citron M., and, Vassar R., (2000b) A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta -secretase. J. Biol. Chem. 275, 37712-37717. (Pubitemid 32004885)
17. Best J. D., Smith D. W., Reilly M. A., et al,. (2007) The novel gamma secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl) cyclohexyl]-1,1,1-trifl uoromethanesulfonamide (MRK-560) reduces amyloid plaque deposition without evidence of notch-related pathology in the Tg2576 mouse. J. Pharmacol. Exp. Ther. 320, 552-558. (Pubitemid 46147933)
18. Birchmeier C., and, Nave K. A., (2008) Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation. Glia 56, 1491-1497.
19. Blennow K., (2010) Biomarkers in Alzheimer's disease drug development. Nat. Med. 16, 1218-1222.
20. Blundell J., Tabuchi K., Bolliger M. F., Blaiss C. A., Brose N., Liu X., Sudhof T. C., and, Powell C. M., (2009) Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2. Genes Brain Behav. 8, 114-126.
21. Boucard A. A., Chubykin A. A., Comoletti D., Taylor P., and, Sudhof T. C., (2005) A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins. Neuron 48, 229-236. (Pubitemid 41476357)
22. Boucard A. A., Ko J., and, Sudhof T. C., (2012) High affinity neurexin binding to cell adhesion G-protein-coupled receptor CIRL1/latrophilin-1 produces an intercellular adhesion complex. J. Biol. Chem. 287, 9399-9413.
23. Bousquet-Moore D., Mains R. E., and, Eipper B. A., (2010) Peptidylgycine alpha-amidating monooxygenase and copper: a gene-nutrient interaction critical to nervous system function. J. Neurosci. Res. 88, 2535-2545.
24. Braas K. M., Stoffers D. A., Eipper B. A., and, May V., (1989) Tissue specific expression of rat peptidylglycine alpha-amidating monooxygenase activity and mRNA. Mol. Endocrinol. 3, 1387-1398. (Pubitemid 19241031)
25. Brunberg E., Andersson L., Cothran G., Sandberg K., Mikko S., and, Lindgren G., (2006) A missense mutation in PMEL17 is associated with the Silver coat color in the horse. BMC Genet. 7, 46.
26. Buggia-Prevot V., Fernandez C. G., Udayar V., et al,. (2013) A function for EHD family proteins in unidirectional retrograde dendritic transport of BACE1 and Alzheimer's disease Aβ production. Cell Rep. 5, 1552-1563.
27. Buggia-Prevot V., Fernandez C. G., Riordan S., Vetrivel K. S., Roseman J., Waters J., Bindokas V. P., Vassar R., and, Thinakaran G., (2014) Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase. Mol. Neurodegener. 9, 1.
28. Cai H., Wang Y., McCarthy D., Wen H., Borchelt D. R., Price D. L., and, Wong P. C., (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat. Neurosci. 4, 233-234. (Pubitemid 32194867)
29. Cai J., Qi X., Kociok N., et al,. (2012) beta-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment. EMBO Mol. Med. 4, 980-991.
30. Cao L., Rickenbacher G. T., Rodriguez S., Moulia T. W., and, Albers M. W., (2012) The precision of axon targeting of mouse olfactory sensory neurons requires the BACE1 protease. Sci. Rep. 2, 231.
31. Capell A., Steiner H., Willem M., Kaiser H., Meyer C., Walter J., Lammich S., Multhaup G., and, Haass C., (2000) Maturation and pro-peptide cleavage of beta-secretase. J. Biol. Chem. 275, 30849-30854.
32. Chami L., and, Checler F., (2012) BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and beta-amyloid production in Alzheimer's disease. Mol. Neurodegener. 7, 52.
33. Chang W. P., Koelsch G., Wong S., et al,. (2004) In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors. J. Neurochem. 89, 1409-1416. (Pubitemid 38802662)
34. Chen Y., Hancock M. L., Role L. W., and, Talmage D. A., (2010) Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons. J. Neurosci. 30, 9199-9208.
35. Cheret C., Willem M., Fricker F. R., et al,. (2013) Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles. EMBO J. 32, 2015-2028.
36. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A. Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., and, Selkoe D. J., (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360, 672-674. (Pubitemid 23007680)
37. Cole D. C., Manas E. S., Stock J. R., et al,. (2006) Acylguanidines as small-molecule beta-secretase inhibitors. J. Med. Chem. 49, 6158-6161.
38. Colombo A., Wang H., Kuhn P. H., Page R., Kremmer E., Dempsey P. J., Crawford H. C., and, Lichtenthaler S. F., (2012) Constitutive alpha- and beta-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines. Neurobiol. Dis. 49C, 137-147.
39. Congreve M., Aharony D., Albert J., et al,. (2007) Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase. J. Med. Chem. 50, 1124-1132. (Pubitemid 46496313)
40. Coric V., van Dyck C. H., Salloway S., et al,. (2012) Safety and tolerability of the gamma-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease. Arch. Neurol. 69, 1430-1440.
41. Couch J. A., Yu Y. J., and, Zhang Y., et al,. (2013) Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier. Sci. Transl. Med., 5, 183ra157, 181-112.
42. Crusio W. E., and, Schwegler H., (2005) Learning spatial orientation tasks in the radial-maze and structural variation in the hippocampus in inbred mice. Behav. Brain Funct. 1, 3.
43. Cumming J. N., Smith E. M., Wang L., et al,. (2012) Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor. Bioorg. Med. Chem. Lett. 22, 2444-2449.
44. Czyzyk T. A., Ning Y., Hsu M. S., Peng B., Mains R. E., Eipper B. A., and, Pintar J. E., (2005) Deletion of peptide amidation enzymatic activity leads to edema and embryonic lethality in the mouse. Dev. Biol. 287, 301-313. (Pubitemid 41636766)
45. Danilczyk U., Sarao R., Remy C., et al,. (2006) Essential role for collectrin in renal amino acid transport. Nature 444, 1088-1091. (Pubitemid 46018530)
46. Dawson G., and, Cho S., (2000) Batten's disease: clues to neuronal protein catabolism in lysosomes. J. Neurosci. Res. 60, 133-140. (Pubitemid 30198619)
47. Dawson G. R., Seabrook G. R., Zheng H., et al,. (1999) Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience 90, 1-13. (Pubitemid 29096448)
48. De Strooper B., Vassar R., and, Golde T., (2010) The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol. 6, 99-107.
49. Dejaegere T., Serneels L., Schafer M. K., et al,. (2008) Deficiency of Aph1B/C-gamma-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment. Proc. Natl. Acad Sci. USA 105, 9775-9780. (Pubitemid 352031376)
50. Deng M., He W., Tan Y., Han H., Hu X., Xia K., Zhang Z., and, Yan R., (2013) Increased expression of reticulon 3 in neurons leads to reduced axonal transport of beta site amyloid precursor protein-cleaving enzyme 1. J. Biol. Chem. 288, 30236-30245.
51. Di Fede G., Catania M., Morbin M., et al,. (2009) A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 323, 1473-1477.
52. Dislich B., and, Lichtenthaler S. F., (2012) The membrane-bound aspartyl protease BACE1: molecular and functional properties in Alzheimer's disease and beyond. Front. Physiol. 3, 8.
53. Dominguez D., Tournoy J., Hartmann D., et al,. (2005) Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice. J. Biol. Chem. 280, 30797-30806. (Pubitemid 41291810)
54. Doody R. S., Raman R., Farlow M., et al,. (2013) A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N. Engl. J. Med. 369, 341-350.
55. Ehehalt R., Keller P., Haass C., Thiele C., and, Simons K., (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160, 113-123. (Pubitemid 36091721)
56. Esterhazy D., Stutzer I., Wang H., et al,. (2011) Bace2 is a beta cell-enriched protease that regulates pancreatic beta cell function and mass. Cell Metab. 14, 365-377.
57. Etherton M. R., Blaiss C. A., Powell C. M., and, Sudhof T. C., (2009) Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc. Natl Acad. Sci. USA 106, 17998-18003.
58. Falls D. L., (2003) Neuregulins and the neuromuscular system: 10 years of answers and questions. J. Neurocytol. 32, 619-647. (Pubitemid 39011250)
59. Farah M. H., Pan B. H., Hoffman P. N., et al,. (2011) Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system. J. Neurosci. 31, 5744-5754.
60. Farzan M., Schnitzler C. E., Vasilieva N., Leung D., and, Choe H., (2000) BACE2, a b-secretase homolog, cleaves at the b site and within the amyloid-b region of the amyloid-b precursor protein. Proc. Natl Acad. Sci. USA 97, 9712-9717. (Pubitemid 30650841)
61. Fleck D., Garratt A. N., Haass C., and, Willem M., (2012) BACE1 dependent neuregulin proteolysis. Curr. Alzheimer Res. 9, 178-183.
62. Fleck D., van Bebber F., Colombo A., et al,. (2013) Dual cleavage of neuregulin 1 type III by BACE1 and ADAM17 liberates its EGF-like domain and allows paracrine signaling. J. Neurosci. 33, 7856-7869.
63. Fluhrer R., Capell A., Westmeyer G., Willem M., Hartung B., Condron M. M., Teplow D. B., Haass C., and, Walter J., (2002) A non-amyloidogenic function of BACE-2 in the secretory pathway. J. Neurochem. 81, 1011-1020. (Pubitemid 34809283)
64. Garratt A. N., Voiculescu O., Topilko P., Charnay P., and, Birchmeier C., (2000) A dual role of erbB2 in myelination and in expansion of the schwann cell precursor pool. J. Cell Biol. 148, 1035-1046.
65. Gersbacher M. T., Kim D. Y., Bhattacharyya R., and, Kovacs D. M., (2010) Identification of BACE1 cleavage sites in human voltage-gated sodium channel beta 2 subunit. Mol. Neurodegener. 5, 61.
66. Geschwindner S., Olsson L. L., Albert J. S., Deinum J., Edwards P. D., de Beer T., and, Folmer R. H., (2007) Discovery of a novel warhead against beta-secretase through fragment-based lead generation. J. Med. Chem. 50, 5903-5911.
67. Ghosh A. K., Brindisi M., and, Tang J., (2012) Developing beta-secretase inhibitors for treatment of Alzheimer's disease. J. Neurochem. 120 (Suppl 1), 71-83.
68. Goldstein J. L., and, Brown M. S., (2009) The LDL receptor. Arterioscler. Thromb. Vasc. Biol. 29, 431-438.
69. Grayton H. M., Missler M., Collier D. A., and, Fernandes C., (2013) Altered social behaviours in neurexin 1alpha knockout mice resemble core symptoms in neurodevelopmental disorders. PLoS ONE 8, e67114.
70. Gunnersen J. M., Kim M. H., Fuller S. J., et al,. (2007) Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons. Neuron 56, 621-639. (Pubitemid 350102029)
71. Haass C., (2004) Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J. 23, 483-488. (Pubitemid 38282380)
72. Haass C., Lemere C. A., Capell A., Citron M., Seubert P., Schenk D., Lannfelt L., and, Selkoe D. J., (1995) The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat. Med. 1, 1291-1296.
73. Haniu M., Denis P., Young Y., et al,. (2000) Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties. J. Biol. Chem. 275, 21099-21106. (Pubitemid 30481802)
74. Hardy J., and, Selkoe D. J., (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
75. Harrison S. M., Harper A. J., Hawkins J., et al,. (2003) BACE1 (beta-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes. Mol. Cell. Neurosci. 24, 646-655. (Pubitemid 37506009)
76. He X., Li F., Chang W. P., and, Tang J., (2005) GGA proteins mediate the recycling pathway of memapsin 2 (BACE). J. Biol. Chem. 280, 11696-11703. (Pubitemid 40418483)
77. Hearing V. J., (2005) Biogenesis of pigment granules: a sensitive way to regulate melanocyte function. J. Dermatol. Sci. 37, 3-14. (Pubitemid 40037573)
78. Heber S., Herms J., Gajic V., et al,. (2000) Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20, 7951-7963.
79. Hemming M. L., Elias J. E., Gygi S. P., and, Selkoe D. J., (2009) Identification of beta-secretase (BACE1) substrates using quantitative proteomics. PLoS ONE 4, e8477.
80. Herms J., Anliker B., Heber S., Ring S., Fuhrmann M., Kretzschmar H., Sisodia S., and, Muller U., (2004) Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. EMBO J. 23, 4106-4115. (Pubitemid 39472431)
81. Heyden A., Angenstein F., Sallaz M., Seidenbecher C., and, Montag D., (2008) Abnormal axonal guidance and brain anatomy in mouse mutants for the cell recognition molecules close homolog of L1 and NgCAM-related cell adhesion molecule. Neuroscience 155, 221-233.
82. Hippenmeyer S., Shneider N. A., Birchmeier C., Burden S. J., Jessell T. M., and, Arber S., (2002) A role for neuregulin1 signaling in muscle spindle differentiation. Neuron 36, 1035-1049. (Pubitemid 36044506)
83. Hitt B. D., Jaramillo T. C., Chetkovich D. M., and, Vassar R., (2010) BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization. Mol. Neurodegener. 5, 31.
84. Hitt B., Riordan S., Kukreja L., Eimer W., Rajapaksha T., and, Vassar R., (2012) beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defects. J. Biol. Chem. 287, 38408-38425.
85. Hong L., Koelsch G., Lin X., Wu S., Terzyan S., Ghosh A. K., Zhang X. C., and, Tang J., (2000) Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science 290, 150-153.
86. Hu X., Hicks C. W., He W., Wong P., Macklin W. B., Trapp B. D., and, Yan R., (2006) Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 9, 1520-1525. (Pubitemid 44862660)
87. Hu X., He W., Diaconu C., Tang X., Kidd G. J., Macklin W. B., Trapp B. D., and, Yan R., (2008) Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. FASEB J. 22, 2970-2980.
88. Hu X., Zhou X., He W., Yang J., Xiong W., Wong P., Wilson C. G., and, Yan R., (2010) BACE1 deficiency causes altered neuronal activity and neurodegeneration. J. Neurosci. 30, 8819-8829.
89. Hu X., He W., Luo X., Tsubota K. E., and, Yan R., (2013) BACE1 regulates hippocampal astrogenesis via the Jagged1-Notch pathway. Cell Rep. 4, 40-49.
90. Hussain I., Powell D., Howlett D. R., et al,. (1999) Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 14, 419-427. (Pubitemid 30026585)
91. Hussain I., Hawkins J., Harrison D., et al,. (2007) Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo. J. Neurochem. 100, 802-809. (Pubitemid 46095629)
92. Isom L. L., (2001) Sodium channel beta subunits: anything but auxiliary. Neuroscientist 7, 42-54. (Pubitemid 32098822)
93. Jack C. R., Jr, Vemuri P., Wiste H. J., et al,. (2012) Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch. Neurol. 69, 856-867.
94. Jamain S., Radyushkin K., Hammerschmidt K., et al,. (2008) Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc. Natl Acad. Sci. USA 105, 1710-1715. (Pubitemid 351346579)
95. Jensen C., Herold P., and, Brunner H. R., (2008) Aliskiren: the first renin inhibitor for clinical treatment. Nat. Rev. Drug Discovery 7, 399-410. (Pubitemid 351619112)
96. Jonsson T., Atwal J. K., Steinberg S., et al,. (2012) A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488, 96-99.
97. Jorissen E., Prox J., Bernreuther C., et al,. (2010) The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J. Neurosci. 30, 4833-4844.
98. Kahn S. E., Hull R. L., and, Utzschneider K. M., (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846. (Pubitemid 46024990)
99. Kalvodova L., Kahya N., Schwille P., Ehehalt R., Verkade P., Drechsel D., and, Simons K., (2005) Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J. Biol. Chem. 280, 36815-36823. (Pubitemid 41587762)
100. Kandalepas P. C., Sadleir K. R., Eimer W. A., Zhao J., Nicholson D. A., and, Vassar R., (2013) The Alzheimer's beta-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques. Acta Neuropathol. 126, 329-352.
101. Kang E. L., Cameron A. N., Piazza F., Walker K. R., and, Tesco G., (2010) Ubiquitin regulates GGA3-mediated degradation of BACE1. J. Biol. Chem. 285, 24108-24119.
102. Kang E. L., Biscaro B., Piazza F., and, Tesco G., (2012) BACE1 protein endocytosis and trafficking are differentially regulated by ubiquitination at lysine 501 and the Di-leucine motif in the carboxyl terminus. J. Biol. Chem. 287, 42867-42880.
103. Kerje S., Sharma P., Gunnarsson U., et al,. (2004) The Dominant white, Dun and Smoky color variants in chicken are associated with insertion/deletion polymorphisms in the PMEL17 gene. Genetics 168, 1507-1518. (Pubitemid 40007364)
104. Kim D. Y., Carey B. W., Wang H., et al,. (2007) BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat. Cell Biol. 9, 755-764. (Pubitemid 47019462)
105. Kim J., Jung S. Y., Lee Y. K., et al,. (2008) Neuroligin-1 is required for normal expression of LTP and associative fear memory in the amygdala of adult animals. Proc. Natl Acad. Sci. USA 105, 9087-9092.
106. Kim D. Y., Gersbacher M. T., Inquimbert P., and, Kovacs D. M., (2011) Reduced sodium channel Na(v)1.1 levels in BACE1-null mice. J. Biol. Chem. 286, 8106-8116.
107. Kinoshita A., Fukumoto H., Shah T., Whelan C. M., Irizarry M. C., and, Hyman B. T., (2003) Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. J. Cell Sci. 116, 3339-3346. (Pubitemid 37038982)
108. Ko M. H., and, Puglielli L., (2009) Two endoplasmic reticulum (ER)/ER Golgi intermediate compartment-based lysine acetyltransferases post-translationally regulate BACE1 levels. J. Biol. Chem. 284, 2482-2492.
109. Kobayashi D., Zeller M., Cole T., Buttini M., McConlogue L., Sinha S., Freedman S., Morris R. G., and, Chen K. S., (2008) BACE1 gene deletion: impact on behavioral function in a model of Alzheimer's disease. Neurobiol. Aging 29, 861-873. (Pubitemid 351601901)
110. von Koch C. S., Zheng H., Chen H., Trumbauer M., Thinakaran G., van der Ploeg L. H., Price D. L., and, Sisodia S. S., (1997) Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol. Aging 18, 661-669. (Pubitemid 28046419)
111. Koh Y. H., von Arnim C. A., Hyman B. T., Tanzi R. E., and, Tesco G., (2005) BACE is degraded via the lysosomal pathway. J. Biol. Chem. 280, 32499-32504. (Pubitemid 41361863)
112. Kuhn P. H., Wang H., Dislich B., Colombo A., Zeitschel U., Ellwart J. W., Kremmer E., Rossner S., and, Lichtenthaler S. F., (2010) ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J. 29, 3020-3032.
113. Kuhn P. H., Koroniak K., Hogl S., et al,. (2012) Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J. 31, 3157-3168.
114. La Marca R., Cerri F., Horiuchi K., et al,. (2011) TACE (ADAM17) inhibits Schwann cell myelination. Nat. Neurosci. 14, 857-865.
115. Laird F. M., Cai H., Savonenko A. V., et al,. (2005) BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J. Neurosci. 25, 11693-11709. (Pubitemid 43098462)
116. Lakadamyali M., Rust M. J., and, Zhuang X., (2006) Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 124, 997-1009. (Pubitemid 43344239)
117. Leu M., Bellmunt E., Schwander M., Farinas I., Brenner H. R., and, Muller U., (2003) Erbb2 regulates neuromuscular synapse formation and is essential for muscle spindle development. Development 130, 2291-2301. (Pubitemid 36722382)
118. Li Z. W., Stark G., Gotz J., Rulicke T., Gschwind M., Huber G., Muller U., and, Weissmann C., (1996) Generation of mice with a 200-kb amyloid precursor protein gene deletion by Cre recombinase-mediated site-specific recombination in embryonic stem cells. Proc. Natl Acad. Sci. USA 93, 6158-6162. (Pubitemid 26190820)
119. Li H., Wang B., Wang Z., Guo Q., Tabuchi K., Hammer R. E., Sudhof T. C., and, Zheng H., (2010) Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP. Proc. Natl Acad. Sci. USA 107, 17362-17367.
120. Lin X., Koelsch G., Wu S., Downs D., Dashti A., and, Tang J., (2000) Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc. Natl Acad Sci. USA 97, 1456-1460. (Pubitemid 30118462)
121. Loy C. T., Schofield P. R., Turner A. M., and, Kwok J. B., (2013) Genetics of dementia. Lancet 383, 828-840.
122. Luo Y., Bolon B., Kahn S., et al,. (2001) Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat. Neurosci. 4, 231-232. (Pubitemid 32194866)
123. Luo Y., Bolon B., Damore M. A., Fitzpatrick D., Liu H., Zhang J., Yan Q., Vassar R., and, Citron M., (2003) BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time. Neurobiol. Dis. 14, 81-88. (Pubitemid 37103182)
124. Luo X., Prior M., He W., et al,. (2011) Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination. J. Biol. Chem. 286, 23967-23974.
125. Magara F., Muller U., Li Z. W., Lipp H. P., Weissmann C., Stagljar M., and, Wolfer D. P., (1999) Genetic background changes the pattern of forebrain commissure defects in transgenic mice underexpressing the beta-amyloid-precursor protein. Proc. Natl Acad. Sci. USA 96, 4656-4661. (Pubitemid 29190392)
126. Malakauskas S. M., Quan H., Fields T. A., McCall S. J., Yu M. J., Kourany W. M., Frey C. W., and, Le T. H., (2007) Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin. Am. J. Physiol. Renal Physiol. 292, F533-F544. (Pubitemid 46220520)
127. May P. C., Dean R. A., Lowe S. L., et al,. (2011) Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor. J. Neurosci. 31, 16507-16516.
128. McConlogue L., Buttini M., Anderson J. P., et al,. (2007) Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP Transgenic Mice. J. Biol. Chem. 282, 26326-26334. (Pubitemid 47443774)
129. Meakin P. J., Harper A. J., Hamilton D. L., et al,. (2012) Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice. Biochem. J. 441, 285-296.
130. Michailov G. V., Sereda M. W., Brinkmann B. G., et al,. (2004) Axonal neuregulin-1 regulates myelin sheath thickness. Science 304, 700-703. (Pubitemid 38560869)
131. Mitterreiter S., Page R. M., Kamp F., et al,. (2010) Bepridil and amiodarone simultaneously target the Alzheimer's disease beta- and gamma-secretase via distinct mechanisms. J. Neurosci. 30, 8974-8983.
132. Miyazaki T., Hashimoto K., Uda A., et al,. (2006) Disturbance of cerebellar synaptic maturation in mutant mice lacking BSRPs, a novel brain-specific receptor-like protein family. FEBS Lett. 580, 4057-4064. (Pubitemid 44037568)
133. Montag-Sallaz M., Schachner M., and, Montag D., (2002) Misguided axonal projections, neural cell adhesion molecule 180 mRNA upregulation, and altered behavior in mice deficient for the close homolog of L1. Mol. Cell. Biol. 22, 7967-7981. (Pubitemid 35217305)
134. Mullan M., Crawford F., Houlden H., Axelman K., Lilius L., Winblad B., and, Lannfelt L., (1992a) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1, 345-347.
135. Muller U., Cristina N., Li Z. W., Wolfer D. P., Lipp H. P., Rulicke T., Brandner S., Aguzzi A., and, Weissmann C., (1994) Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene. Cell 79, 755-765.
136. Naus S., Richter M., Wildeboer D., Moss M., Schachner M., and, Bartsch J. W., (2004) Ectodomain shedding of the neural recognition molecule CHL1 by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death. J. Biol. Chem. 279, 16083-16090. (Pubitemid 38509299)
137. Ohno M., Sametsky E. A., Younkin L. H., Oakley H., Younkin S. G., Citron M., Vassar R., and, Disterhoft J. F., (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41, 27-33. (Pubitemid 38071826)
138. Ohno M., Chang L., Tseng W., Oakley H., Citron M., Klein W. L., Vassar R., and, Disterhoft J. F., (2006) Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Eur. J. Neurosci. 23, 251-260.
139. Ohno M., Cole S. L., Yasvoina M., Zhao J., Citron M., Berry R., Disterhoft J. F., and, Vassar R., (2007) BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiol. Dis. 26, 134-145. (Pubitemid 46436493)
140. Pastorino L., Ikin A. F., Nairn A. C., Pursnani A., and, Buxbaum J. D., (2002) The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total A(beta). Mol. Cell. Neurosci. 19, 175-185. (Pubitemid 34211898)
141. Perez R. G., Soriano S., Hayes J. D., Ostaszewski B., Xia W., Selkoe D. J., Chen X., Stokin G. B., and, Koo E. H., (1999) Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J. Biol. Chem. 274, 18851-18856.
142. Phinney A. L., Calhoun M. E., Wolfer D. P., Lipp H. P., Zheng H., and, Jucker M., (1999) No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-amyloid precursor protein-null mice. Neuroscience 90, 1207-1216. (Pubitemid 29170139)
143. Plenge R. M., Scolnick E. M., and, Altshuler D., (2013) Validating therapeutic targets through human genetics. Nat. Rev. Drug Discovery 12, 581-594.
144. Poliak S., Salomon D., Elhanany H., et al,. (2003) Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J. Cell Biol. 162, 1149-1160. (Pubitemid 37174196)
145. Pomara N., (2013) Semagacestat for treatment of Alzheimer's disease. N. Engl. J. Med. 369, 1661.
146. Prabhu Y., Burgos P. V., Schindler C., Farias G. G., Magadan J. G., and, Bonifacino J. S., (2012) Adaptor protein 2-mediated endocytosis of the beta-secretase BACE1 is dispensable for amyloid precursor protein processing. Mol. Biol. Cell 23, 2339-2351.
147. Rajagopal C., Stone K. L., Mains R. E., and, Eipper B. A., (2010) Secretion stimulates intramembrane proteolysis of a secretory granule membrane enzyme. J. Biol. Chem. 285, 34632-34642.
148. Rajapaksha T. W., Eimer W. A., Bozza T. C., and, Vassar R., (2011) The Alzheimer's beta-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb. Mol. Neurodegener. 6, 88.
149. Rajendran L., and, Simons K., (2008) Membrane Trafficking and Targeting in Alzheimer's disease. Foundation Ipsen Series, Springer, Heidelberg, Berlin.
150. Rajendran L., Honsho M., Zahn T. R., Keller P., Geiger K. D., Verkade P., and, Simons K., (2006) Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc. Natl Acad. Sci. USA 103, 11172-11177. (Pubitemid 44156491)
151. Rajendran L., Schneider A., Schlechtingen G., et al,. (2008) Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting. Science 320, 520-523. (Pubitemid 351590663)
152. Raposo G., and, Marks M. S., (2007) Melanosomes-dark organelles enlighten endosomal membrane transport. Nat. Rev. Mol. Cell Biol. 8, 786-797. (Pubitemid 47462136)
153. Ray S., Fatima Z., and, Saxena A., (2010) Drugs for AIDS. Mini Rev. Med. Chem. 10, 147-161.
154. Ring S., Weyer S. W., Kilian S. B., et al,. (2007) The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. J. Neurosci. 27, 7817-7826. (Pubitemid 47093823)
155. Roberds S. L., Anderson J., Basi G., et al,. (2001) BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum. Mol. Genet. 10, 1317-1324. (Pubitemid 32600485)
156. Rochin L., Hurbain I., Serneels L., et al,. (2013) BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells. Proc. Natl Acad Sci. USA 110, 10658-10663.
157. Rogaeva E., Meng Y., Lee J. H., et al,. (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 39, 168-177. (Pubitemid 46184347)
158. Rossner S., Sastre M., Bourne K., and, Lichtenthaler S. F., (2006) Transcriptional and translational regulation of BACE1 expression-implications for Alzheimer's disease. Prog. Neurobiol. 79, 95-111. (Pubitemid 44247281)
159. Saftig P., Hetman M., Schmahl W., et al,. (1995) Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J. 14, 3599-3608.
160. Sakano H., (2010) Neural map formation in the mouse olfactory system. Neuron 67, 530-542.
161. Sankaranarayanan S., Price E. A., Wu G., et al,. (2008) In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1. J. Pharmacol. Exp. Ther. 324, 957-969. (Pubitemid 351397853)
162. Sankaranarayanan S., Holahan M. A., Colussi D., et al,. (2009) First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates. J. Pharmacol. Exp. Ther. 328, 131-140.
163. Sannerud R., Declerck I., Peric A., et al,. (2011) ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1. Proc. Natl Acad. Sci. USA 108, E559-E568.
164. Savonenko A. V., Melnikova T., Laird F. M., Stewart K. A., Price D. L., and, Wong P. C., (2008) Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc. Natl Acad. Sci. USA 105, 5585-5590. (Pubitemid 351753906)
165. Savvaki M., Panagiotaropoulos T., Stamatakis A., Sargiannidou I., Karatzioula P., Watanabe K., Stylianopoulou F., Karagogeos D., and, Kleopa K. A., (2008) Impairment of learning and memory in TAG-1 deficient mice associated with shorter CNS internodes and disrupted juxtaparanodes. Mol. Cell. Neurosci. 39, 478-490.
166. Schneider A., Rajendran L., Honsho M., Gralle M., Donnert G., Wouters F., Hell S. W., and, Simons M., (2008) Flotillin-dependent clustering of the amyloid precursor protein regulates its endocytosis and amyloidogenic processing in neurons. J. Neurosci. 28, 2874-2882. (Pubitemid 351398889)
167. Seabrook G. R., Smith D. W., Bowery B. J., et al,. (1999) Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology 38, 349-359. (Pubitemid 29097718)
168. Shacka J. J., Klocke B. J., Young C., Shibata M., Olney J. W., Uchiyama Y., Saftig P., and, Roth K. A., (2007) Cathepsin D deficiency induces persistent neurodegeneration in the absence of Bax-dependent apoptosis. J. Neurosci. 27, 2081-2090.
169. Shih D. Q., Screenan S., Munoz K. N., Philipson L., Pontoglio M., Yaniv M., Polonsky K. S., and, Stoffel M., (2001) Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50, 2472-2480. (Pubitemid 33642764)
170. Siegenthaler B. M., and, Rajendran L., (2012) Retromers in Alzheimer's disease. Neurodegener. Dis. 10, 116-121.
171. Siintola E., Partanen S., Stromme P., Haapanen A., Haltia M., Maehlen J., Lehesjoki A. E., and, Tyynela J., (2006) Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129, 1438-1445. (Pubitemid 43999376)
172. Sinha S., Anderson J. P., Barbour R., et al,. (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537-540.
173. Sisodia S. S., and, St George-Hyslop P. H., (2002) gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat. Rev. Neurosci. 3, 281-290. (Pubitemid 135706607)
174. Small S. A., and, Gandy S., (2006) Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis. Neuron 52, 15-31. (Pubitemid 44466354)
175. Stamford A., and, Strickland C., (2013) Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story. Curr. Opin. Chem. Biol. 17, 320-328.
176. Stamford A. W., Scott J. D., Li S. W., et al,. (2012) Discovery of an orally available, brain penetrant BACE1 inhibitor that affords robust CNS abeta reduction. ACS Med. Chem. Lett. 3, 897-902.
177. Steinbach J. P., Muller U., Leist M., Li Z. W., Nicotera P., and, Aguzzi A., (1998) Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice. Cell Death Differ. 5, 858-866. (Pubitemid 28484396)
178. Stutzer I., Selevsek N., Esterhazy D., Schmidt A., Aebersold R., and, Stoffel M., (2013) Systematic proteomic analysis identifies beta-site amyloid precursor protein cleaving enzyme 2 and 1 (BACE2 and BACE1) substrates in pancreatic beta-cells. J. Biol. Chem. 288, 10536-10547.
179. Suh J., Choi S. H., Romano D. M., Gannon M. A., Lesinski A. N., Kim D. Y., and, Tanzi R. E., (2013) ADAM10 missense mutations potentiate beta-amyloid accumulation by impairing prodomain chaperone function. Neuron 80, 385-401.
180. Suzuki K., Hayashi Y., Nakahara S., et al,. (2012) Activity-dependent proteolytic cleavage of neuroligin-1. Neuron 76, 410-422.
181. Tanzi R. E., (2012) The genetics of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2.
182. Taveggia C., Zanazzi G., Petrylak A., et al,. (2005) Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47, 681-694. (Pubitemid 41208007)
183. Tesco G., Koh Y. H., Kang E. L., et al,. (2007) Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 54, 721-737. (Pubitemid 46843521)
184. Theos A. C., Berson J. F., Theos S. C., et al,. (2006) Dual loss of ER export and endocytic signals with altered melanosome morphology in the silver mutation of Pmel17. Mol. Biol. Cell 17, 3598-3612. (Pubitemid 44156452)
185. Thisse B., Heyer V., Lux A., Alunni V., Degrave A., Seiliez I., Kirchner J., Parkhill J. P., and, Thisse C., (2004) Spatial and temporal expression of the zebrafish genome by large-scale in situ hybridization screening. Methods Cell Biol. 77, 505-519.
186. Tong G., Wang J. S., Sverdlov O., et al,. (2012) Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral gamma-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers. Clin. Ther. 34, 654-667.
187. Traka M., Goutebroze L., Denisenko N., et al,. (2003) Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J. Cell Biol. 162, 1161-1172. (Pubitemid 37174197)
188. Udayar V., Buggia-Prevot V., Guerreiro R. L., et al,. (2013) A Paired RNAi and RabGAP overexpression screen identifies Rab11 as a regulator of beta-amyloid production. Cell Rep. 5, 1536-1551.
189. Varoqueaux F., Aramuni G., Rawson R. L., Mohrmann R., Missler M., Gottmann K., Zhang W., Sudhof T. C., and, Brose N., (2006) Neuroligins determine synapse maturation and function. Neuron 51, 741-754. (Pubitemid 44374915)
190. Vassar R., Bennett B. D., Babu-Khan S., et al,. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
191. Vassar R., Kovacs D. M., Yan R., and, Wong P. C., (2009) The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J. Neurosci. 29, 12787-12794.
192. Vetrivel K. S., Meckler X., Chen Y., et al,. (2009) Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts. J. Biol. Chem. 284, 3793-3803.
193. Walker K. R., and, Tesco G., (2013) Molecular mechanisms of cognitive dysfunction following traumatic brain injury. Front. Aging Neurosci. 5, 29.
194. Walsh D. M., and, Selkoe D. J., (2007) A beta oligomers-a decade of discovery. J. Neurochem. 101, 1172-1184.
195. Wan H. I., Jacobsen J. S., Rutkowski J. L., and, Feuerstein G. Z., (2009) Translational medicine lessons from flurizan's failure in Alzheimer's disease (AD) trial: implication for future drug discovery and development for AD. Clin. Transl. Sci. 2, 242-247.
196. Wang P., Yang G., Mosier D. R., et al,. (2005) Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J. Neurosci. 25, 1219-1225. (Pubitemid 40268964)
197. Wang Y. S., Strickland C., Voigt J. H., et al,. (2010) Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors. J. Med. Chem. 53, 942-950.
198. Watt B., van Niel G., Fowler D. M., et al,. (2009) N-terminal domains elicit formation of functional Pmel17 amyloid fibrils. J. Biol. Chem. 284, 35543-35555.
199. Weyer S. W., Klevanski M., Delekate A., et al,. (2011) APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP. EMBO J. 30, 2266-2280.
200. Willem M., Garratt A. N., Novak B., et al,. (2006) Control of peripheral nerve myelination by the beta-secretase BACE1. Science 314, 664-666. (Pubitemid 44646394)
201. Willem M., Lammich S., and, Haass C., (2009) Function, regulation and therapeutic properties of beta-secretase (BACE1). Semin. Cell Dev. Biol. 20, 175-182.
202. Wong H. K., Sakurai T., Oyama F., et al,. (2005) beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase. J. Biol. Chem. 280, 23009-23017. (Pubitemid 40853211)
203. Xu J. Y., Xia Q. Q., and, Xia J., (2012) A review on the current neuroligin mouse models. Sheng Li Xue Bao 64, 550-562.
204. Yan R., Bienkowski M. J., Shuck M. E., et al,. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533-537.
205. Yan R., Munzner J. B., Shuck M. E., and, Bienkowski M. J., (2001) BACE2 functions as an alternative alpha-secretase in cells. J. Biol. Chem. 276, 34019-34027.
206. Yang G., Gong Y. D., Gong K., et al,. (2005) Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2. Neurosci. Lett. 384, 66-71. (Pubitemid 40826619)
207. Yang L., Wang Z., Wang B., Justice N. J., and, Zheng H., (2009a) Amyloid precursor protein regulates Cav1.2 L-type calcium channel levels and function to influence GABAergic short-term plasticity. J. Neurosci. 29, 15660-15668.
208. Yang W., Fucini R. V., Fahr B. T., et al,. (2009b) Fragment-based discovery of nonpeptidic BACE-1 inhibitors using tethering. Biochemistry 48, 4488-4496.
209. Yu Y. J., Zhang Y., and, Kenrick M., et al,. (2011) Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci. Transl. Med. 3, 84ra44.
210. Zhang H., Wada J., Hida K., et al,. (2001) Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J. Biol. Chem. 276, 17132-17139.
211. Zheng H., Jiang M., Trumbauer M. E., et al,. (1995) beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81, 525-531.
212. Zhou L., Barao S., Laga M., et al,. (2012) The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo. J. Biol. Chem. 287, 25927-25940.
213. Zhu Z., Sun Z. Y., Ye Y., et al,. (2010) Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: part I-inhibitor design and validation. J. Med. Chem. 53, 951-965.